Stifel Downgrades Inspire Medical Systems to Hold, Announces $210 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Jonathan Block has downgraded Inspire Medical Systems (NYSE:INSP) from Buy to Hold and set a price target of $210.
January 02, 2024 | 10:35 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Inspire Medical Systems was downgraded by Stifel from Buy to Hold with a new price target of $210.
Downgrades typically suggest that the analyst sees limited upside potential or increased risk, which could lead to a neutral or negative reaction in the stock price in the short term. However, the establishment of a price target at $210 may provide some support to the stock price, indicating that the downgrade is not based on a negative outlook but rather on valuation reaching the analyst's perceived fair value.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100